Evidence map›Paper›PMID 39598428›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Cremastrae Pseudobulbus Pleiones Pseudobulbus (CPPP) Against Non-Small-Cell Lung Cancer: Elucidating Effective Ingredients and Mechanism of Action.

Yuxin Cao, Zhuangzhuang Hao, Mengmeng Liu, Jingwen Xue, Yuqing Wang, Yu Wang, Jiayuan Li, Yifan Lu, Chunguo Wang, Jinli Shi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Application and mechanism ofAmerican journal of translational research · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuxin CaoSchool of Chinese Medica Materia, Beijing University of Chinese Medicine, Beijing 100029, China.
Zhuangzhuang HaoSchool of Chinese Medica Materia, Beijing University of Chinese Medicine, Beijing 100029, China.
Mengmeng LiuSchool of Chinese Medica Materia, Beijing University of Chinese Medicine, Beijing 100029, China.
Jingwen XueSchool of Chinese Medica Materia, Beijing University of Chinese Medicine, Beijing 100029, China.
Yuqing WangSchool of Chinese Medica Materia, Beijing University of Chinese Medicine, Beijing 100029, China.
Yu WangSchool of Chinese Medica Materia, Beijing University of Chinese Medicine, Beijing 100029, China.
Jiayuan LiSchool of Chinese Medica Materia, Beijing University of Chinese Medicine, Beijing 100029, China.
Yifan LuSchool of Chinese Medica Materia, Beijing University of Chinese Medicine, Beijing 100029, China.
Chunguo WangInstitute of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China.ORCID 0000-0002-2711-1144
Jinli ShiSchool of Chinese Medica Materia, Beijing University of Chinese Medicine, Beijing 100029, China.

Funding

National Natural Science Foundation of China 82073971
6 · The paper itself

Abstract

Cremastrae Pseudobulbus Pleiones Pseudobulbus (CPPP) is derived from the dried pseudobulb of the orchid family plants

Indexed as

action mechanismsAMPK-mTOR-ULK1/BMF signaling pathwayCremastrae Pseudobulbus Pleiones Pseudobulbuseffective ingredient combinationsnon-small-cell lung cancerserum pharmacochemistryspectrum–effect relationships

Identifiers

PMID39598428
PMCPMC11597303

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.